110 related articles for article (PubMed ID: 3240067)
1. [Antiaggregative and anticoagulant effects of oligoamines. 8. Oligoamines with N-heterocyclic space structures].
Rehse K; Mletzko S
Arch Pharm (Weinheim); 1988 Sep; 321(9):533-6. PubMed ID: 3240067
[No Abstract] [Full Text] [Related]
2. [Antiaggregatory and anticoagulant effects of oligoamines. 7. Benzene-1,3,5-trialkaneamines].
Rehse K; Lükens U; Claus G
Arch Pharm (Weinheim); 1987 Dec; 320(12):1233-8. PubMed ID: 3439865
[No Abstract] [Full Text] [Related]
3. [Anti-aggregatory and anticoagulant properties of oligoamines. 11. Oligoamines with two primary amine groups].
Rehse K; Rose B; Leissring S
Arch Pharm (Weinheim); 1990 Feb; 323(2):103-8. PubMed ID: 2334273
[TBL] [Abstract][Full Text] [Related]
4. [Antiaggregatory and anticoagulant effects of oligoamines. 10. Tertiary oligoamines and quaternary ammonium salts].
Rehse K; Kämpfe M
Arch Pharm (Weinheim); 1989 Nov; 322(11):811-5. PubMed ID: 2624527
[TBL] [Abstract][Full Text] [Related]
5. [Antiaggregatory and anticoagulant effects of oligoamines. 5. Alicyclic di- and triamines].
Rehse K; Carstensen A; Ernst HJ
Arch Pharm (Weinheim); 1987 Sep; 320(9):829-36. PubMed ID: 3675171
[No Abstract] [Full Text] [Related]
6. [Antiaggregatory and anticoagulant effects of oligoamines. 12. Alkyl- and arylalkyl- derivatives of putrescine, spermidine and spermine].
Rehse K; Puchert E; Leissring S
Arch Pharm (Weinheim); 1990 May; 323(5):287-94. PubMed ID: 2383171
[TBL] [Abstract][Full Text] [Related]
7. Platelet aggregation inhibiting and anticoagulant effects of oligoamines, XXVIII: Oligoamines with fluorescent properties. Part C: Fluorescent oligoamines with enhanced hydrophilic properties.
Rehse K; Seidel T
Arch Pharm (Weinheim); 1995 Feb; 328(2):131-5. PubMed ID: 7726738
[TBL] [Abstract][Full Text] [Related]
8. [Anti-aggregatory and anticoagulant effects of oligoamines. 9. The pharmacokinetics of N,N',N"-tris-4-(3-iodo-4-methoxyphenyl)-butyl-1,3,5-benzene triethanamine].
Rehse K; Buck W; Wenzel M
Arch Pharm (Weinheim); 1988 Nov; 321(11):813-6. PubMed ID: 3219050
[No Abstract] [Full Text] [Related]
9. Platelet aggregation inhibiting and anticoagulant effects of oligoamines, XV: Antithrombotic effect of selected oligoamines in rats.
Rehse K; Kesselhut A; Schein V; Kämpfe M; Rose B; Unsöld E
Arch Pharm (Weinheim); 1991 May; 324(5):301-5. PubMed ID: 1888267
[TBL] [Abstract][Full Text] [Related]
10. Platelet aggregation inhibiting and anticoagulant effects of oligoamines, XVII: Oligoamines with fluorescent properties. Part A: Fluorescent bridged nitrogen functions.
Rehse K; Seidel T
Arch Pharm (Weinheim); 1992 Apr; 325(4):235-9. PubMed ID: 1530456
[TBL] [Abstract][Full Text] [Related]
11. Platelet aggregation inhibiting and anticoagulant effects of oligoamines, XVIII: Oligoamines with fluorescent properties, Part B: Fluorophores in the molecular periphery.
Rehse K; Seidel T
Arch Pharm (Weinheim); 1994 Jun; 327(6):399-404. PubMed ID: 8048847
[TBL] [Abstract][Full Text] [Related]
12. [Anti-aggregatory and anticoagulant effects of oligoamines. 6. Oligohydroxyalkane diamines].
Rehse K; Claus G; Leissring S
Arch Pharm (Weinheim); 1987 Nov; 320(11):1155-61. PubMed ID: 3439860
[No Abstract] [Full Text] [Related]
13. Platelet aggregation inhibiting and anticoagulant effects of oligoamines, XIV: Branched aliphatic and alicyclic triamines and tetramines.
Rehse K; Kesselhut A; Schein V; Leissring S
Arch Pharm (Weinheim); 1991 Apr; 324(4):243-7. PubMed ID: 1863203
[TBL] [Abstract][Full Text] [Related]
14. Platelet aggregation inhibiting and anticoagulant effects of oligoamines, XXII: Bisoxazol-, bisimidazol-, bisthiazol- and oligo-1,2,4-thiadiazolimines.
Rehse K; Martens A
Arch Pharm (Weinheim); 1993 Jul; 326(7):399-404. PubMed ID: 8357302
[TBL] [Abstract][Full Text] [Related]
15. Platelet aggregation inhibiting and anticoagulant effects of oligoamines, XX: 4,4',4''-(1,3,5)-benzene-tris-sydnone imines.
Rehse K; Martens A
Arch Pharm (Weinheim); 1993 Apr; 326(4):217-9. PubMed ID: 8494483
[TBL] [Abstract][Full Text] [Related]
16. Platelet aggregation inhibiting and anticoagulant effects of oligoamines, XXI: 4,4'-Alkylene-bis-sydnone imines.
Rehse K; Martens A
Arch Pharm (Weinheim); 1993 May; 326(5):307-11. PubMed ID: 8328885
[TBL] [Abstract][Full Text] [Related]
17. Platelet aggregation inhibiting and anticoagulant effects of oligoamines, Part 33. From tetradecane- to octacosanediamines.
Rehse K; Nolte-Driller R
Arch Pharm (Weinheim); 1996 Apr; 329(4):191-6. PubMed ID: 8669983
[TBL] [Abstract][Full Text] [Related]
18. Platelet aggregation inhibiting and anticoagulant effects of oligoamines, XIX: 4,4'-Phenylene-bis-sydnone imines.
Rehse K; Kämpfe M; Martens A
Arch Pharm (Weinheim); 1993 Mar; 326(3):163-6. PubMed ID: 8481095
[TBL] [Abstract][Full Text] [Related]
19. [Anti-aggregation and anticoagulant effects of oligoamines. 3. M-phenylenebisaminoalkanes].
Rehse K; Lükens U; Leissring S; Claus G
Arch Pharm (Weinheim); 1987 Mar; 320(3):228-33. PubMed ID: 3579524
[No Abstract] [Full Text] [Related]
20. Platelet aggregation inhibiting and anticoagulant effects of oligoamines, XVI: Cytostatic and cytotoxic side effects of oligoamines.
Rehse K; Noack B; Maurer R; Hilgard P
Arch Pharm (Weinheim); 1991 Oct; 324(10):797-801. PubMed ID: 1805711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
